ArticleCancer management and research2021

Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma.

Yong-Pyo Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.